TOFRANIL Side Effects

5571476-1 | Cerebrovascular Disorder, Condition Aggravated, Decreased Appetite, Hallucination, Auditory, Nystagmus, Vertigo Positional
on Dec 13, 2007 Female patient from JAPAN , 54 years of age, was diagnosed with major depression and was treated with Tofranil (View Usage). Patient experienced the following unwanted or unexpected effects: cerebrovascular disorder, condition aggravated, decreased appetite, hallucination, auditory, nystagmus, vertigo positional. Tofranil dosage: 75 Mg/d. During the same period patient was treated with MILNACIPRAN HYDROCHLORIDE (50 Mg/d) (View Milnacipran Hydrochloride Review and Milnacipran Hydrochloride Label ), AMOXAPINE (150 Mg/d) (View Amoxapine Review and Amoxapine Label ). Patient was hospitalized.

5521688-8 | Anxiety, Brain Natriuretic Peptide Increased, Depressed Level Of Consciousness, Dyspnoea, Hyperglycaemia, Insomnia, Loss Of Consciousness, Malaise, Mental Disorder
Patient was taking Tofranil (View Usage). Patient had the following side effects: anxiety (What is anxiety?), brain natriuretic peptide increased, depressed level of consciousness, dyspnoea, hyperglycaemia, insomnia, loss of consciousness, malaise, mental disorder on Nov 15, 2007 from JAPAN Additional patient health information: Female patient , 58 years of age, weighting 108.0 lb, was diagnosed with depression (What is depression?), anxiety (What is anxiety?) and. Tofranil dosage: 20 Mg/d. During the same period patient was treated with AMOXAPINE (75 Mg/d) (View Amoxapine Review and Amoxapine Label ), SEPAZON (6 Mg/day) (View Sepazon Review and Sepazon Label ). Patient was hospitalized.

5490401-5 | Abdominal Pain, Agitation, Alopecia, Arrhythmia, Constipation, Dry Mouth, Ear Operation, Euphoric Mood, Feeling Hot
Adverse event was reported on Oct 15, 2007 by a Female patient taking Tofranil (View Usage) (Dosage: 25 Mg, 5qd) was diagnosed with panic disorder (What is panic disorder?), nervousness, hypertension and. Location: BRAZIL , 30 years of age, weighting 174.2 lb, After Tofranil was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), agitation, alopecia, arrhythmia (What is arrhythmia?), constipation (What is constipation?), dry mouth, ear operation, euphoric mood, feeling hot. During the same period patient was treated with LORAX (1 Mg, Bid) (View Lorax Review and Lorax Label ), ATENOLOL W/CHLORTALIDONE (100/25 Mg/day) (View Atenolol W/chlortalidone Review and Atenolol W/chlortalidone Label ).

5480117-3 | Alanine Aminotransferase Increased, Anorexia, Aspartate Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Human Herpes Virus 6 Serology Positive, Liver Disorder, Pyrexia
on Oct 01, 2007 Female patient from JAPAN , 48 years of age, was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and was treated with Tofranil (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, blood lactate dehydrogenase increased, human herpes virus 6 serology positive, liver disorder, pyrexia. Tofranil dosage: Unk, Unk. During the same period patient was treated with POLYCARBOPHIL CALCIUM (Unk, Unk) (View Polycarbophil Calcium Review and Polycarbophil Calcium Label ), THIATON (Unk, Unk) (View Thiaton Review and Thiaton Label ), LANSOPRAZOLE (Unk, Unk) (View Lansoprazole Review and Lansoprazole Label ), SEDIEL (View Sediel Review and Sediel Label ), TRANCOLON (View Trancolon Review and Trancolon Label ). Patient was hospitalized.


5479166-0 | Cerebrovascular Disorder, Condition Aggravated, Decreased Appetite, Hallucination, Auditory, Nystagmus, Vertigo Positional
on Sep 28, 2007 Female patient from JAPAN , 54 years of age, was diagnosed with major depression and was treated with Tofranil (View Usage). Patient had the following side effects: cerebrovascular disorder, condition aggravated, decreased appetite, hallucination, auditory, nystagmus, vertigo positional. Tofranil dosage: 50 Mg/d. During the same period patient was treated with MILNACIPRAN HYDROCHLORIDE (50 Mg/d) (View Milnacipran Hydrochloride Review and Milnacipran Hydrochloride Label ), AMOXAPINE (100 Mg/d) (View Amoxapine Review and Amoxapine Label ). Patient was hospitalized.

5476873-0 | Blood Creatine Phosphokinase Increased, Haemodialysis, Rhabdomyolysis, Serotonin Syndrome
Patient was taking Tofranil (View Usage). After Tofranil was administered, patient had the following side effects: blood creatine phosphokinase increased, haemodialysis, rhabdomyolysis, serotonin syndrome on Oct 01, 2007 from SPAIN Additional patient health information: Female patient , 50 years of age, was diagnosed with major depression and. Tofranil dosage: 150 Mg/day. During the same period patient was treated with VENLAFAXINE HCL (150 Mg/day) (View Venlafaxine Hcl Review and Venlafaxine Hcl Label ), TRANKIMAZIN (3 Mg/day) (View Trankimazin Review and Trankimazin Label ), CINITAPRIDE (3 Mg, Tid) (View Cinitapride Review and Cinitapride Label ), ZYPREXA (5 Mg, Qd) (View Zyprexa Review and Zyprexa Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), ANAFRANIL (150 Mg/day) (View Anafranil Review and Anafranil Label ). Patient was hospitalized.

5451006-5 | Delusion, Depression, Insomnia, Poor Quality Sleep, Restlessness, Somnolence
Adverse event was reported on Jul 20, 2006 by a Female patient taking Tofranil (View Usage) (Dosage: 25 Mg, 3-4 Tablets At Night, Qd, Oral) was diagnosed with sleep disorder (What is sleep disorder?) and. Location: UNITED STATES , 47 years of age, weighting 278.0 lb, Patient experienced the following unwanted or unexpected effects: delusion, depression (What is depression?), insomnia, poor quality sleep, restlessness, somnolence. Patient was hospitalized.

5443066-2 | Blood Glucose Increased, Hyperglycaemia, Loss Of Consciousness, Tachycardia
on Aug 29, 2007 Female patient from JAPAN , 58 years of age, was treated with Tofranil (View Usage). Patient had the following side effects: blood glucose increased, hyperglycaemia, loss of consciousness, tachycardia. Tofranil dosage: 20 Mg/d. During the same period patient was treated with AMOXAN (75 Mg/d) (View Amoxan Review and Amoxan Label ), SEPAZON (View Sepazon Review and Sepazon Label ). Patient was hospitalized.

5441322-5 | Alanine Aminotransferase Increased, Anorexia, Aspartate Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Human Herpes Virus 6 Serology Positive, Liver Disorder, Pyrexia
on Aug 27, 2007 Female patient from JAPAN , 48 years of age, was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and was treated with Tofranil (View Usage). After Tofranil was administered, patient had the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, blood lactate dehydrogenase increased, human herpes virus 6 serology positive, liver disorder, pyrexia. Tofranil dosage: Unk, Unk. During the same period patient was treated with POLYCARBOPHIL CALCIUM (Unk, Unk) (View Polycarbophil Calcium Review and Polycarbophil Calcium Label ), THIATON (Unk, Unk) (View Thiaton Review and Thiaton Label ), LANSOPRAZOLE (Unk, Unk) (View Lansoprazole Review and Lansoprazole Label ), SEDIEL (View Sediel Review and Sediel Label ), TRANCOLON (View Trancolon Review and Trancolon Label ). Patient was hospitalized.

5441313-4 | Arrhythmia, Blood Pressure Decreased, Cardio-respiratory Arrest, Depressed Level Of Consciousness, Electrocardiogram Qt Prolonged, Glossoptosis, Intubation, Life Support, Overdose
Patient was taking Tofranil (View Usage). Patient experienced the following unwanted or unexpected effects: arrhythmia (What is arrhythmia?), blood pressure decreased, cardio-respiratory arrest, depressed level of consciousness, electrocardiogram qt prolonged, glossoptosis, intubation, life support, overdose on Aug 30, 2007 from JAPAN Additional patient health information: Female patient , 32 years of age, weighting 99.21 lb, was diagnosed with depression (What is depression?) and. Tofranil dosage: . During the same period patient was treated with TRIAZOLAM (3.25 Mg, Once/single) (View Triazolam Review and Triazolam Label ), CLOXAZOLAM (172 Mg, Once/single) (View Cloxazolam Review and Cloxazolam Label ), BROMAZEPAM (50 Mg, Once/single) (View Bromazepam Review and Bromazepam Label ), FLUNITRAZEPAM (20 Mg, Once/single) (View Flunitrazepam Review and Flunitrazepam Label ). Patient was hospitalized.

5409270-4 | Aphthous Stomatitis, Dyskinesia, Insomnia, Somnolence
Adverse event was reported on Aug 03, 2007 by a Female patient taking Tofranil (View Usage) (Dosage: 25 Mg, Bid) was diagnosed with epilepsy (What is epilepsy?), procedural pain and. Location: BRAZIL , 45 years of age, weighting 105.8 lb, Patient had the following side effects: aphthous stomatitis, dyskinesia, insomnia, somnolence. During the same period patient was treated with GARDAN TAB (100 Mg, Bid) (View Gardan Tab Review and Gardan Tab Label ), TENOXICAM (20 Mg, Bid) (View Tenoxicam Review and Tenoxicam Label ), CYCLOBENZAPRINE HCL (10 Mg, Q8h) (View Cyclobenzaprine Hcl Review and Cyclobenzaprine Hcl Label ), RANITIDINE (150 Mg, Q12h) (View Ranitidine Review and Ranitidine Label ).

5396218-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Liver Disorder, Pyrexia
on Jul 18, 2007 Female patient from JAPAN , 48 years of age, was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and was treated with Tofranil (View Usage). After Tofranil was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, liver disorder, pyrexia. Tofranil dosage: . During the same period patient was treated with POLYCARBOPHIL CALCIUM (View Polycarbophil Calcium Review and Polycarbophil Calcium Label ), THIATON (View Thiaton Review and Thiaton Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ). Patient was hospitalized.

5391147-4 | Blepharospasm, Conversion Disorder, Myoclonus
on Jul 10, 2007 Female patient from FRANCE , 17 years of age, weighting 119.0 lb, was treated with Tofranil (View Usage). Patient experienced the following unwanted or unexpected effects: blepharospasm, conversion disorder, myoclonus. Tofranil dosage: 20 Mg, Once/single. During the same period patient was treated with PRIMPERAN /SCH/ (Unk, Prn) (View Primperan /sch/ Review and Primperan /sch/ Label ). Patient was hospitalized.

5388955-2 | Depressed Level Of Consciousness, Electrocardiogram Qt Prolonged, Glossoptosis, Overdose, Shock, Ventricular Tachycardia
Patient was taking Tofranil (View Usage). Patient had the following side effects: depressed level of consciousness, electrocardiogram qt prolonged, glossoptosis, overdose, shock, ventricular tachycardia on Jul 09, 2007 from JAPAN Additional patient health information: Female patient , 32 years of age, was diagnosed with depression (What is depression?) and. Tofranil dosage: . Patient was hospitalized.

5388943-6 | Cataract, Erythema, Headache, Mass, Mydriasis, Poisoning
Adverse event was reported on Jul 09, 2007 by a Female patient taking Tofranil (View Usage) (Dosage: 75 Mg/d) was diagnosed with depression (What is depression?), alcoholism (What is alcoholism?), anxiety (What is anxiety?) and. Location: BRAZIL , 33 years of age, weighting 141.1 lb, After Tofranil was administered, patient had the following side effects: cataract (What is cataract?), erythema, headache (What is headache?), mass, mydriasis, poisoning (What is poisoning?). During the same period patient was treated with DISULFIRAM (1 Spoon Daily) (View Disulfiram Review and Disulfiram Label ), RIVOTRIL (4 Mg, Bid) (View Rivotril Review and Rivotril Label ), NEOZINE (25 Mg, Bid) (View Neozine Review and Neozine Label ), CHLORDIAZEPOXIDE (25 Mg, Bid) (View Chlordiazepoxide Review and Chlordiazepoxide Label ), BIOTONICO (1 Spoon) (View Biotonico Review and Biotonico Label ).

5381629-3 | Depressed Level Of Consciousness, Glossoptosis, Overdose, Shock, Ventricular Tachycardia
on Jun 27, 2007 Female patient from JAPAN , 32 years of age, was diagnosed with depression (What is depression?) and was treated with Tofranil (View Usage). Patient experienced the following unwanted or unexpected effects: depressed level of consciousness, glossoptosis, overdose, shock, ventricular tachycardia. Tofranil dosage: . Patient was hospitalized.

5348875-6 | Liver Disorder
on May 28, 2007 Male patient from JAPAN , 54 years of age, was treated with Tofranil (View Usage). Patient had the following side effects: liver disorder. Tofranil dosage: 25 Mg/d.

5313775-4 | Congestive Cardiomyopathy, Crepitations, Ejection Fraction Decreased, Electrocardiogram T Wave Inversion, Heart Rate Increased, Hepatojugular Reflux, Hypokinesia, Oedema Peripheral, Pulmonary Oedema
Patient was taking Tofranil (View Usage). After Tofranil was administered, patient had the following side effects: congestive cardiomyopathy, crepitations, ejection fraction decreased, electrocardiogram t wave inversion, heart rate increased, hepatojugular reflux, hypokinesia, oedema peripheral, pulmonary oedema on Apr 12, 2007 from FRANCE Additional patient health information: Female patient , 56 years of age, was diagnosed with bipolar disorder (What is bipolar disorder?) and. Tofranil dosage: 20 Mg, Qd. Patient was hospitalized.

5293214-2 | Abdominal Pain, Agitation, Arrhythmia, Constipation, Dry Mouth, Ear Operation, Euphoric Mood, Feeling Hot, Hyperhidrosis
Adverse event was reported on Mar 30, 2007 by a Female patient taking Tofranil (View Usage) (Dosage: 25 Mg, 5qd) was diagnosed with panic disorder (What is panic disorder?), nervousness and. Location: BRAZIL , 45 years of age, weighting 174.2 lb, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), agitation, arrhythmia (What is arrhythmia?), constipation (What is constipation?), dry mouth, ear operation, euphoric mood, feeling hot, hyperhidrosis. During the same period patient was treated with LORAX (1 Mg, Bid) (View Lorax Review and Lorax Label ).

5280006-3 | Disturbance In Attention, Fall, Tremor
on Mar 16, 2007 Male patient from SWITZERLAND , 64 years of age, was diagnosed with bipolar disorder (What is bipolar disorder?) and was treated with Tofranil (View Usage). Patient had the following side effects: disturbance in attention, fall (What is fall?), tremor. Tofranil dosage: 150 Mg/d. During the same period patient was treated with DEPAKENE (1500 Mg/d) (View Depakene Review and Depakene Label ), LAMICTAL (75 Mg/d) (View Lamictal Review and Lamictal Label ).

5258557-7 | Abnormal Behaviour, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Creatine Phosphokinase Increased, Blood Glucose Increased, Blood Lactate Dehydrogenase Increased, Blood Pressure Increased, Body Temperature Decreased
on Feb 23, 2007 Male patient from JAPAN , 61 years of age, was diagnosed with depression (What is depression?) and was treated with Tofranil (View Usage). After Tofranil was administered, patient had the following side effects: abnormal behaviour, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood creatine phosphokinase increased, blood glucose increased, blood lactate dehydrogenase increased, blood pressure increased, body temperature decreased. Tofranil dosage: 75 Mg/day. During the same period patient was treated with TETRAMIDE (30 Mg/day) (View Tetramide Review and Tetramide Label ), TRYPTANOL (75 Mg/day) (View Tryptanol Review and Tryptanol Label ), DEPAS (View Depas Review and Depas Label ), CONSTAN (View Constan Review and Constan Label ), DOGMATYL (View Dogmatyl Review and Dogmatyl Label ). Patient was hospitalized.

5257133-X | Abdominal Pain Upper, Blood Bilirubin Abnormal, Liver Disorder
Patient was taking Tofranil (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, blood bilirubin abnormal, liver disorder on Feb 22, 2007 from BRAZIL Additional patient health information: Female patient , 60 years of age, was diagnosed with depression (What is depression?) and. Tofranil dosage: 25 Mg/d.

5256100-X | Blood Albumin Decreased, Blood Blister, Blood Cholesterol Decreased, Coma, Erythema, Overdose, Protein Total Decreased, Rash, Skin Erosion
Adverse event was reported on Feb 21, 2007 by a Female patient taking Tofranil (View Usage) (Dosage: 25 Mg, Once/single) . Location: JAPAN , 23 years of age, Patient had the following side effects: blood albumin decreased, blood blister, blood cholesterol decreased, coma, erythema, overdose, protein total decreased, rash (What is rash?), skin erosion. During the same period patient was treated with HALCION (10 Tabs Of 0.25 Mg) (View Halcion Review and Halcion Label ). Patient was hospitalized.

5247744-X | Abnormal Behaviour, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Glucose Increased, Blood Lactate Dehydrogenase Increased, Blood Pressure Increased, Body Temperature Decreased, Communication Disorder
on Feb 14, 2007 Male patient from JAPAN , 61 years of age, was treated with Tofranil (View Usage). After Tofranil was administered, patient had the following side effects: abnormal behaviour, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood glucose increased, blood lactate dehydrogenase increased, blood pressure increased, body temperature decreased, communication disorder. Tofranil dosage: 75 Mg/day. During the same period patient was treated with TETRAMIDE (30 Mg/day) (View Tetramide Review and Tetramide Label ), TRYPTANOL /AUS/ (75 Mg/day) (View Tryptanol /aus/ Review and Tryptanol /aus/ Label ). Patient was hospitalized.

5235875-X | Blood Pressure Decreased, Cardiac Failure Congestive, Cardiomegaly, Congestive Cardiomyopathy, Dyspnoea Exertional, Ejection Fraction Decreased, Electrocardiogram T Wave Inversion, Hepatojugular Reflux, Oedema Peripheral
on Jan 30, 2007 Female patient from FRANCE , 57 years of age, weighting 174.2 lb, was diagnosed with bipolar i disorder and was treated with Tofranil (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, cardiac failure congestive, cardiomegaly, congestive cardiomyopathy, dyspnoea exertional, ejection fraction decreased, electrocardiogram t wave inversion, hepatojugular reflux, oedema peripheral. Tofranil dosage: 20 Mg/day. Patient was hospitalized.

5230375-5 | Hallucination, Insomnia, Pyrexia
Patient was taking Tofranil (View Usage). Patient had the following side effects: hallucination, insomnia, pyrexia on Jan 26, 2007 from BRAZIL Additional patient health information: Male patient , 13 years of age, weighting 136.7 lb, was diagnosed with convulsion and. Tofranil dosage: 10 Mg, Qd.

5211754-9 | Hyponatraemia
Adverse event was reported on Jan 09, 2007 by a Female patient taking Tofranil (View Usage) (Dosage: 3 Df, Qd) . Location: FRANCE , 81 years of age, After Tofranil was administered, patient had the following side effects: hyponatraemia. During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ), QUITAXON (1 Df, Qd) (View Quitaxon Review and Quitaxon Label ), ASPIRIN (75 Mg, Qd) (View Aspirin Review and Aspirin Label ), TEMESTA (2.5 Mg, Qd) (View Temesta Review and Temesta Label ). Patient was hospitalized.

5199739-2 | Hyperkalaemia
on Dec 25, 2006 Female patient from JAPAN , 81 years of age, was diagnosed with depression (What is depression?) and was treated with Tofranil (View Usage). Patient experienced the following unwanted or unexpected effects: hyperkalaemia. Tofranil dosage: 25 Mg, Bid.

5197078-7 | Hyperkalaemia
on Dec 21, 2006 Female patient from JAPAN , 81 years of age, was treated with Tofranil (View Usage). Patient had the following side effects: hyperkalaemia. Tofranil dosage: 25 Mg, Bid.

5128460-1 | Abnormal Behaviour, Face Oedema, Intentional Overdose, Somnolence, Suicide Attempt, Vomiting
Patient was taking Tofranil (View Usage). After Tofranil was administered, patient had the following side effects: abnormal behaviour, face oedema, intentional overdose, somnolence, suicide attempt, vomiting on Oct 03, 2006 from BRAZIL Additional patient health information: Male patient , 27 years of age, weighting 154.3 lb, was diagnosed with incorrect dose administered and. Tofranil dosage: 400 Mg, Once/single. During the same period patient was treated with DIAZEPAM (4 Df, Once/single) (View Diazepam Review and Diazepam Label ).

5114060-6 | Alanine Aminotransferase Increased, Anorexia, Aspartate Aminotransferase Increased, Back Pain, Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased, Blood Pressure Decreased, Body Temperature Decreased, Cough
Adverse event was reported on Jul 27, 2006 by a Female patient taking Tofranil (View Usage) (Dosage: 10 Mg, Qd) was diagnosed with back pain (What is back pain?), osteoporosis (What is osteoporosis?) and. Location: JAPAN , 83 years of age, weighting 77.16 lb, Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, back pain (What is back pain?), blood alkaline phosphatase increased, blood lactate dehydrogenase increased, blood pressure decreased, body temperature decreased, cough. During the same period patient was treated with ELCITONIN (20 Iu, Qw) (View Elcitonin Review and Elcitonin Label ), BONALON (5 Mg/day) (View Bonalon Review and Bonalon Label ), JUZENTAIHOTO (3 G, Tid) (View Juzentaihoto Review and Juzentaihoto Label ), GLAKAY (15 Mg, Tid) (View Glakay Review and Glakay Label ).

5112498-4 | Constipation, Diverticular Perforation, Diverticulitis, Peritonitis
on Aug 31, 2006 Female patient from JAPAN , 73 years of age, was treated with Tofranil (View Usage). Patient had the following side effects: constipation (What is constipation?), diverticular perforation, diverticulitis, peritonitis. Tofranil dosage: 10 Mg/d.

5103717-9 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Gamma-glutamyltransferase Increased, Liver Disorder, Pyrexia
on Jul 26, 2006 Male patient from JAPAN , 79 years of age, weighting 147.7 lb, was diagnosed with benign prostatic hyperplasia and was treated with Tofranil (View Usage). After Tofranil was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, liver disorder, pyrexia. Tofranil dosage: 10 Mg/d. During the same period patient was treated with HARNAL (0.2 Mg/d) (View Harnal Review and Harnal Label ). Patient was hospitalized.

5101577-3 | Constipation, Diverticular Perforation, Diverticulitis, Peritonitis
Patient was taking Tofranil (View Usage). Patient experienced the following unwanted or unexpected effects: constipation (What is constipation?), diverticular perforation, diverticulitis, peritonitis on Aug 31, 2006 from JAPAN Additional patient health information: Female patient , 73 years of age, . Tofranil dosage: 10 Mg/d.

5093078-6 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Gamma-glutamyltransferase Increased, Liver Disorder, Pyrexia
Adverse event was reported on Jul 26, 2006 by a Male patient taking Tofranil (View Usage) (Dosage: 10 Mg/d) was diagnosed with benign prostatic hyperplasia and. Location: JAPAN , 79 years of age, weighting 147.7 lb, Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, liver disorder, pyrexia. During the same period patient was treated with HARNAL (0.2 Mg/d) (View Harnal Review and Harnal Label ). Patient was hospitalized.

5089838-8 | Glossitis, Glossodynia, Oral Pain
on Mar 29, 2006 Female patient from JAPAN , 56 years of age, weighting 101.4 lb, was diagnosed with panic disorder (What is panic disorder?) and was treated with Tofranil (View Usage). After Tofranil was administered, patient had the following side effects: glossitis, glossodynia, oral pain. Tofranil dosage: . During the same period patient was treated with MEILAX (1 Mg/d) (View Meilax Review and Meilax Label ). Patient was hospitalized.

5085526-2 | Blood Alkaline Phosphatase Increased, Gamma-glutamyltransferase Increased, Liver Disorder
on Jul 26, 2006 Male patient from JAPAN , 81 years of age, was treated with Tofranil (View Usage). Patient experienced the following unwanted or unexpected effects: blood alkaline phosphatase increased, gamma-glutamyltransferase increased, liver disorder. Tofranil dosage: 20 Mg/d. During the same period patient was treated with GASLON (View Gaslon Review and Gaslon Label ), ATARAX (View Atarax Review and Atarax Label ). Patient was hospitalized.

5084697-1 | Glossitis, Glossodynia, Oral Pain
Patient was taking Tofranil (View Usage). Patient had the following side effects: glossitis, glossodynia, oral pain on Mar 29, 2006 from JAPAN Additional patient health information: Female patient , 56 years of age, weighting 101.4 lb, was diagnosed with panic disorder (What is panic disorder?) and. Tofranil dosage: . During the same period patient was treated with MEILAX (1 Mg/d) (View Meilax Review and Meilax Label ). Patient was hospitalized.

5081841-7 | Headache, Nervousness, Night Sweats
Adverse event was reported on Jul 10, 2006 by a Female patient taking Tofranil (View Usage) (Dosage: 25 Mg, Qid) . Location: BELGIUM , 65 years of age, After Tofranil was administered, patient had the following side effects: headache (What is headache?), nervousness, night sweats.

5073416-0 | Agitation, Anxiety, Delirium, Insomnia, Sleep Disorder
on Jul 14, 2006 Female patient from BRAZIL , 36 years of age, weighting 125.7 lb, was diagnosed with depression (What is depression?), anxiety (What is anxiety?) and was treated with Tofranil (View Usage). Patient experienced the following unwanted or unexpected effects: agitation, anxiety (What is anxiety?), delirium, insomnia, sleep disorder (What is sleep disorder?). Tofranil dosage: 10 Mg, Tid. During the same period patient was treated with OXCARBAZEPINE (200 Mg/d) (View Oxcarbazepine Review and Oxcarbazepine Label ), URBANYL (20 Mg, Qhs) (View Urbanyl Review and Urbanyl Label ), CARBAMAZEPINE (200 Mg, Bid) (View Carbamazepine Review and Carbamazepine Label ).

5073415-9 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Liver Disorder, Pyrexia
on Jul 26, 2006 Male patient from JAPAN , 79 years of age, was diagnosed with benign prostatic hyperplasia and was treated with Tofranil (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, liver disorder, pyrexia. Tofranil dosage: . During the same period patient was treated with HARNAL (0.2 Mg/d) (View Harnal Review and Harnal Label ). Patient was hospitalized.

5073406-8 | Blood Alkaline Phosphatase Increased, Gamma-glutamyltransferase Increased, Liver Disorder
Patient was taking Tofranil (View Usage). After Tofranil was administered, patient had the following side effects: blood alkaline phosphatase increased, gamma-glutamyltransferase increased, liver disorder on Jul 26, 2006 from JAPAN Additional patient health information: Male patient , 81 years of age, . Tofranil dosage: 20 Mg/d. During the same period patient was treated with GASLON (View Gaslon Review and Gaslon Label ), ATARAX (View Atarax Review and Atarax Label ). Patient was hospitalized.

5060651-0 | Blood Creatine Phosphokinase Increased, Muscle Rigidity, Neuroleptic Malignant Syndrome, Pyrexia
Adverse event was reported on Jul 05, 2006 by a Female patient taking Tofranil (View Usage) (Dosage: 150 Mg/d) was diagnosed with major depression and. Location: JAPAN , 50 years of age, Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased, muscle rigidity, neuroleptic malignant syndrome, pyrexia. During the same period patient was treated with RISPERIDONE (6 Mg/d) (View Risperidone Review and Risperidone Label ), OLANZAPINE (25 Mg/d) (View Olanzapine Review and Olanzapine Label ), CHLORPROMAZINE (25 Mg/d) (View Chlorpromazine Review and Chlorpromazine Label ), SULPIRIDE (NGX) (150 Mg/d) (View Sulpiride (ngx) Review and Sulpiride (ngx) Label ), AMOXAPINE (225 Mg/d) (View Amoxapine Review and Amoxapine Label ), PAROXETINE (20 Mg/d) (View Paroxetine Review and Paroxetine Label ), FLUVOXAMINE MALEATE (50 Mg/d) (View Fluvoxamine Maleate Review and Fluvoxamine Maleate Label ). Patient was hospitalized.

5058236-5 | Blood Creatine Phosphokinase Increased, Muscle Rigidity, Neuroleptic Malignant Syndrome, Pyrexia
on Jul 05, 2006 Female patient from JAPAN , 50 years of age, was diagnosed with major depression and was treated with Tofranil (View Usage). Patient had the following side effects: blood creatine phosphokinase increased, muscle rigidity, neuroleptic malignant syndrome, pyrexia. Tofranil dosage: 150 Mg/d. During the same period patient was treated with RISPERIDONE (6 Mg/d) (View Risperidone Review and Risperidone Label ), OLANZAPINE (25 Mg/d) (View Olanzapine Review and Olanzapine Label ), CHLORPROMAZINE (25 Mg/d) (View Chlorpromazine Review and Chlorpromazine Label ), SULPIRIDE (NGX) (150 Mg/d) (View Sulpiride (ngx) Review and Sulpiride (ngx) Label ), AMOXAPINE (225 Mg/d) (View Amoxapine Review and Amoxapine Label ), PAROXETINE (20 Mg/d) (View Paroxetine Review and Paroxetine Label ), FLUVOXAMINE MALEATE (50 Mg/d) (View Fluvoxamine Maleate Review and Fluvoxamine Maleate Label ). Patient was hospitalized.

5049548-X | Glossitis, Glossodynia, Hypoaesthesia Oral, Oral Discomfort, Oral Pain
on Mar 29, 2006 Female patient from JAPAN , 56 years of age, weighting 101.4 lb, was diagnosed with panic disorder (What is panic disorder?) and was treated with Tofranil (View Usage). After Tofranil was administered, patient had the following side effects: glossitis, glossodynia, hypoaesthesia oral, oral discomfort, oral pain. Tofranil dosage: . During the same period patient was treated with MEILAX (1 Mg/d) (View Meilax Review and Meilax Label ). Patient was hospitalized.

5041939-6 | Adrenal Insufficiency, Anaesthetic Complication, Blood Pressure Diastolic Decreased, Blood Pressure Systolic Increased, Heart Rate Decreased, Hypovolaemia, Operative Haemorrhage, Procedural Hypotension
Patient was taking Tofranil (View Usage). Patient experienced the following unwanted or unexpected effects: adrenal insufficiency, anaesthetic complication, blood pressure diastolic decreased, blood pressure systolic increased, heart rate decreased, hypovolaemia, operative haemorrhage, procedural hypotension on Jun 19, 2006 from JAPAN Additional patient health information: Female patient , 74 years of age, weighting 110.2 lb, was diagnosed with depression (What is depression?) and. Tofranil dosage: 20 Mg, Qd, Unk. During the same period patient was treated with LOFEPRAMINE (LOFEPRAMINE) (75 Mg, Qd, Unk) (View Lofepramine (lofepramine) Review and Lofepramine (lofepramine) Label ), LIDOCAINE (View Lidocaine Review and Lidocaine Label ), EPINEPHRINE (View Epinephrine Review and Epinephrine Label ), PROPOFOL (View Propofol Review and Propofol Label ), VERCURONIUM (VECURONIUM) (View Vercuronium (vecuronium) Review and Vercuronium (vecuronium) Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), NITROUS OXIDE W/ OXYGEN (View Nitrous Oxide W/ Oxygen Review and Nitrous Oxide W/ Oxygen Label ), OXYGEN (OXYGEN) (View Oxygen (oxygen) Review and Oxygen (oxygen) Label ).

5040228-3 | Haematocrit Decreased, Orthostatic Hypotension
Adverse event was reported on Jun 21, 2006 by a Female patient taking Tofranil (View Usage) (Dosage: 150 Mg/d) was diagnosed with depression (What is depression?), hypertension and. Location: SPAIN , 74 years of age, Patient had the following side effects: haematocrit decreased, orthostatic hypotension. During the same period patient was treated with ATENOLOL (100 Mg, Bid) (View Atenolol Review and Atenolol Label ), TRYPTIZOL (25 Mg/d) (View Tryptizol Review and Tryptizol Label ). Patient was hospitalized.

5028493-X | Blood Sodium Decreased, Headache, Hypoaesthesia, Hyponatraemia, Polydipsia, Thirst
on May 24, 2006 Male patient from JAPAN , 80 years of age, weighting 136.7 lb, was treated with Tofranil (View Usage). After Tofranil was administered, patient had the following side effects: blood sodium decreased, headache (What is headache?), hypoaesthesia, hyponatraemia, polydipsia, thirst. Tofranil dosage: Unk, Unk. Patient was hospitalized.

5022036-2 | Depression, Gastric Ulcer, Gastritis, Gastrointestinal Disorder, Headache, Malaise, Somnolence, Stomach Discomfort, Surgery
on May 29, 2006 Female patient from BRAZIL , 40 years of age, weighting 141.1 lb, was diagnosed with obsessive-compulsive disorder (What is obsessive-compulsive disorder?) and was treated with Tofranil (View Usage). Patient experienced the following unwanted or unexpected effects: depression (What is depression?), gastric ulcer, gastritis, gastrointestinal disorder, headache (What is headache?), malaise, somnolence, stomach discomfort, surgery (What is surgery?). Tofranil dosage: . During the same period patient was treated with FELDENE (View Feldene Review and Feldene Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ), INIBEX S (View Inibex S Review and Inibex S Label ), PAROXETINE HYDROCHLORIDE (View Paroxetine Hydrochloride Review and Paroxetine Hydrochloride Label ), SEROQUEL (View Seroquel Review and Seroquel Label ), VENLAFAXINE HCL (View Venlafaxine Hcl Review and Venlafaxine Hcl Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ), CONCERTA (54 Mg/d) (View Concerta Review and Concerta Label ).

5022032-5 | Head Discomfort, Headache, Hemiparesis
Patient was taking Tofranil (View Usage). Patient had the following side effects: head discomfort, headache (What is headache?), hemiparesis on Jan 11, 2006 from BRAZIL Additional patient health information: Female patient , 48 years of age, weighting 154.3 lb, was diagnosed with bladder disorder and. Tofranil dosage: 25 Mg, Qd.